title: Olestra formulation and the gastrointestinal tract.
abstract: Olestra is a mixture of compounds comprising sucrose esterified with 6-8 long-chain fatty acids. It is not hydrolyzed by pancreatic lipase and as a result is not absorbed from the small intestine. Olestra in general has physical properties similar to those of a triacylglycerol with the same fatty acid composition. Foods made with olestra are virtually identical in taste and texture to those made with typical triacylglycerols. Olestra consumption does not generate hydrolytic products in the small intestine and, therefore, does not generate some of the signals that alter motility in the gastrointestinal tract. A reduction in gastroesophageal reflux with olestra, in contrast to triacylglycerols, is consistent with a lack of effect on stomach emptying. Unlike triacylglycerols that are absorbed in the proximal small intestine, olestra is distributed throughout the small intestine during transit and passes into the colon. In the colon, olestra's effects depend on its physical properties. Liquid nondigestible lipids result in separation of oil from the fecal matrix. Olestra formulations made with specific fatty acid compositions, particularly those containing a solid sucrose polyester component including behenic acid, possess appropriate rheology to hinder separation of oil from the rest of the fecal matrix, thereby reducing gastrointestinal symptoms.
authors.affiliation: Procter & Gamble Miami Valley Laboratories and Winton Hill Technical Center, Cincinnati, Ohio 45253-8707, USA. jandacek.rj@pg.com
authors.forename: R J
authors.initials: RJ
authors.lastname: Jandacek
authors.forename: J J
authors.initials: JJ
authors.lastname: Kester
authors.forename: A J
authors.initials: AJ
authors.lastname: Papa
authors.forename: T J
authors.initials: TJ
authors.lastname: Wehmeier
authors.forename: P Y
authors.initials: PY
authors.lastname: Lin
mesh_terms: D000818:Animals; D004042:Dietary Fats, Unsaturated / Q000494:pharmacology; D004064:Digestive System / Q000187:drug effects*; D019358:Fat Substitutes / Q000494:pharmacology; D005227:Fatty Acids / Q000494:pharmacology*; D006801:Humans; D009055:Mouth / Q000187:drug effects; D013395:Sucrose / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D004042:Dietary Fats, Unsaturated; D019358:Fat Substitutes; D005227:Fatty Acids; D013395:Sucrose; C013692:sucrose polyester